foot in Biological Technology

Innocoll Announces Provisional Findings From Its Three Phase 2 Clinical Trials Investigating CollaRx(R) GENTAMICIN TOPICAL for the Treatment and Prevention of Diabetic Foot Infections

... treatment and prevention of infection in diabetic foot ulcers. Chronic ulcerations such as diabetic foot ulcers are often colonized or contaminated with ... indicated for the treatment of infected diabetic foot ulcers. CollaRx GENTAMICIN TOPICAL is a ...

Beckman Coulter Announces First Quarter 2009 Results

... ====== ======== (1) Amounts may not foot due to rounding. (2) Constant currency growth ... ====== ====== (1) Amounts may not foot due to rounding (2) Includes Eastern Europe, ... ====== ======== (1) Amounts may not foot due to rounding. ...

Sinovac Reports Unaudited Full Year 2008 and Fourth Quarter Financial Results with Financial Tables

... enterovirus 71 (EV 71), which causes hand, foot and mouth disease. Development is ... product given the severity of recent hand, foot and mouth disease outbreak in China and other ... As the developer of a vaccine against hand, foot and mouth disease, Sinovac is well positioned to ...

Sinovac Reports Unaudited Full Year 2008 and Fourth Quarter Financial Results

... enterovirus 71 (EV 71), which causes hand, foot and mouth disease. Development is ... product given the severity of recent hand, foot and mouth disease outbreak in China and other ... As the developer of a vaccine against hand, foot and mouth disease, Sinovac is well positioned to ...

The University of Arizona College of Medicine and OmegaGenesis Announce Collaboration Agreement to Address Diabetic Foot Ulcers

... on potential remedies to address diabetic foot ulcers. The agreement includes joint work ... and patients globally. Diabetic foot ulcers are painful, open sores that develop on ... If not diagnosed and treated promptly, diabetic foot ulcers can cause extensive damage to soft-tissue ...

Beckman Coulter Announces Fourth Quarter and Full Year 2008 Results; Earnings Outlook Achieved on Strong Fundamentals

... ======== ======== (1) Amounts may not foot due to rounding. (2) Constant currency growth ... ====== ====== ======== (1) Amounts may not foot due to rounding. ... ======== ======== (1) Amounts may not foot due to rounding (2) Includes Eastern Europe, ...

Victhom Human Bionics Receives CE Mark for the Neurostep(TM) System, the World's First Fully Implantable Closed-Loop Neuromodulation Therapy for Treatment of Foot Drop

... product designed to treat gait disorders (e.g., foot drop), is the first CLS product aimed at using ... the Neurostep(TM) will experience remedy to their foot drop and an improved walking pattern that should ... pursue plans for bringing this new solution for foot drop therapy to patients in the United States. ...

Victhom Announces Launch of Enhanced Company Website

... and a particular aspect of gait disorder known as foot drop. This section presents contemporary treatment options for foot drop sufferers as well as the emerging use of ... to restore mobility to persons suffering from foot drop. Information about the product includes a ...

Cardium Reports on Third Quarter 2008 Financial Results and Revised Business Strategies for Operating Units

... the potential treatment of non-healing diabetic foot ulcers, compared to other treatments that require ... the potential treatment of non-healing diabetic foot ulcers and is expected to enroll up to ... the potential treatment of non-healing diabetic foot ulcers. Other potential applications for TRC's ...

NanoVibronix Receives FDA Clearance for its PainShield(TM) MD Device

... Dr. Jonathan Rosenblum, Director, Diabetic foot Service; Shaarei Zedek Medical Center, Jerusalem, ... that it is highly effective in treating painful foot disorders including heel spur syndrome, tendon ... of PainShield on patients suffering from diabetic foot ulcers and initial results are very promising." ...

Bioness Announces NESS H200 and L300 Systems to Be Available at 88 HealthSouth Hospitals Nationwide

... Rehabilitation System and the NESS L300™ foot Drop System to 88 rehabilitation hospitals ... including muscle spasms. The NESS L300 foot Drop System is designed to help patients suffering from foot drop walk more safely and easily. The ...

Beckman Coulter Announces Second Quarter 2008 Results

... 17.3% 12.8% Note: Amounts may not foot due to rounding. * Constant currency growth as ... $712.0 $2,528.5 Note: Amounts may not foot due to rounding. ... 17.3% 12.8% Note: Amounts may not foot due to rounding. * Includes Eastern Europe, ...

EnzySurge, Maker of DermaStream(TM), Announces the Formation of its Scientific Advisory Board

... past Chair of Scientific Sessions for the ADA's foot Care Council, and a past member of the National ... and co-chair of the International Diabetic foot Conference (DF-Con), the largest annual ... artery disease to prevent stroke, diabetic foot problems, limb salvage using ...

PAL Health Technologies Debuts Xtremityscan System at Western Podiatric Medical Congress

... that allows users to acquire three-dimensional foot shapes in seconds, without the ... in 1976, PAL offers a full line of custom foot orthotics through the Xtremityscan System and is ... leading domestic suppliers of prescription foot and ankle orthoses. Based in Pekin, Illinois, PAL ...

Victhom announces promising results on the proof of concept for its unique closed-loop neuromodulation system

... for the treatment of patients suffering from foot drop secondary to a central nervous system ... the appropriate muscle group to lift the foot in the desired direction and in synchronization ... designed to treat gait disorders (e.g., foot drop), is the first CLS product aimed at using ...

Derma Sciences Announces Clinical Poster on Use of MEDIHONEY(TM) Wound & Burn Dressings Wins First Place Award at APWCA

... presented by Dr. Matt Regulski, DPM, Toms River foot and Ankle Surgical Associates, New Jersey. The ... types -- behind pressure ulcers and diabetic foot ulcers -- we have good reason to believe that ... larger cohort studies planned for both diabetic foot ulcers and pressure ulcers, and based on the ...

Innocoll Announces Closing of $30 Million Equity Financing Investment

... the treatment and prevention of infected diabetic foot ulcers and CollaRx BUPIVACAINE IMPLANT for the ... treatment and prevention of diabetic foot infections in patients with moderately infected, ... indicated for the treatment of infected diabetic foot ulcers and recent market research independently ...

Medical Breakthrough ... Doctor Discovers 'Penetrating Carrier' That Eradicates Fungus

... of a new, healthy nail. Cure Athlete's foot unique formulation allows it to work on contact ... Ringworm within 48 hours. Cure Athlete's foot also relieves the itching, burning, and scaling ... toenail fungus (Onychomycosis) and athlete's foot (Tenia Pedis), respectively, without side ....

Alexandria Real Estate Equities, Inc. Reports Third Quarter 2007 Results

... Leases Footage Rates Rates Change foot Terms ... Leases Footage Rates Rates Change foot Terms ... Submarkets opment Dates foot Total Property Status ------------- ...

UCLA welcomes startup to new incubator space at California NanoSystems Institute

... diabetic patients with peripheral neuropathy the loss of sensation in the foot and those with health issues affecting balance who are at high risk of ... will help to reduce the large number of injuries caused by diabetic foot ulcers and by falls each year, both in hospital rehabilitation departments ...

EFT BioTech Holdings, Inc.'s Subsidiary Receives First Permit to Cross Taiwan Strait

... between Taiwan and Mainland China. Excalibur's OceanLaLa vessel is 207 foot long, 52 foot wide and is capable of carrying over 300 tons of cargo and 370 passengers. ...

Cardium Announces Conference Call and Webcast to Review Recent Developments and Future Plans for the Excellarate(TM) Clinical Development Program

... Excellarate product candidate for the potential treatment of non-healing foot ulcers in patients with type I or type II diabetes. In addition, on May ... once or twice for the potential treatment of non-healing diabetic foot ulcers. Other potential applications for TRC's Gene Activated Matrix(TM) ...

Osteotech Reports First Quarter 2009 Financial Results

... technology suite to learn about how Plexur P can be utilized in specific foot and ankle, trauma and joint revision procedures. ... of new procedure-specific instrumentation sets for spinal facet fusion and foot and ankle surgical procedures. The creation of these instrumentation sets ...

Innocoll, Inc. Files 510 (k) Application for CollaRx Lidocaine Sponge

... from chronic wounds (venous stasis ulcers, pressure ulcers, diabetic foot ulcers, etc.) 35 percent of all chronic wounds do not heal within 5 ... Gentamicin Topical for the treatment and prevention of infected diabetic foot ulcers and CollaRx Bupivacaine Implant for the management of ...

Bio-Matrix Scientific Group CEO Tells Wall Street Transcript That 'Positive Cash Flow' Is Possible in '09; New Stem Cell Banking Facility Is Growth Vehicle Over the Next Two Years, Says CEO in Exclusive News Interview

... issue. According to Koos, Bio-Matrix's cGMP compliant 15,000 square foot cryogenic stem cell banking facility is highly secured and technologically ... the growing worldwide stem cell research market. Its new 15,000 square foot facility houses two secure cryogenic stem cell banks, three research ...

Mouse study reveals genetic component of empathy

... in a test chamber and trained to associate a 30-second tone with a mild foot shock. Upon experiencing the shock, the test mouse emitted a short distress call or squeak. Though having no direct knowledge of the foot shock, observers from a very social mouse strain learned from the distress ...

Sopherion Therapeutics, LLC Announces Publication of Phase I/II Myocet(R) (Nonpegylated Liposomal Doxorubicin) Data in Advanced Breast Cancer Patients

... and CEO of Sopherion Therapeutics. "Moreover, the incidence of hand foot syndrome, a rate limiting toxicity of other liposomal anthracyclines, is ... delivery system does not encompass pegylation and yields very little hand foot syndrome. The results of the SOLTI study further support an ongoing ...

Gene Therapy Field Advances With Important Clinical Findings Reported in the New England Journal of Medicine

... of Excellarate for the potential treatment of non-healing diabetic foot ulcers." About Cardium Cardium Therapeutics, Inc. and its ... once or twice for the potential treatment of non-healing diabetic foot ulcers. Other potential applications for TRC's Gene Activated Matrix(TM) ...

Wound Management Technologies, Inc. Announces a Published Case Study

... states Cathy Bradshaw, President of Wound Care Innovations. "Diabetic foot wounds with infections can be complicated and can require multiple ... the United States, it is estimated that 15-20% of diabetics will develop a foot ulcer in their lifetime and that 14-24% of these ulcers will result in ...

BioMed Realty Trust Reports Third Quarter 2008 Financial Results

... in the third quarter 2007 -- Completed delivery of the 84,000 square foot build-to-suit laboratory and office facility at our Towne Centre Drive ... 52,000 square feet, including an approximately 28,000 square foot lease with Nteryx, Inc. at our Ardenwood Boulevard property in the ...

Annual List of 'Best Doctors in Dallas' Showcases Texas Institute for Surgery Physicians

... back and spine surgery, ENT procedures, sports medicine, plastic surgery, foot and ankle surgery, and urological surgical care. Doctors included in ... back and spinal surgery, ENT procedures, sports medicine, plastic surgery, foot and ankle surgery, urological surgical care, sports medicine. For more ...

Access Pharmaceuticals Signs Merger Agreement to Acquire MacroChem Corp.

... Pexiganan, a novel topical anti-infective for the treatment of diabetic foot infection that has already completed two Phase 3 clinical trials; EcoNail, ... Pexiganan, a novel topical anti-infective for the treatment of diabetic foot infection, was recently in-licensed and has already completed two Phase 3 ...

Cardium Reports on First Quarter 2008 Highlights and Financial Results

... of Excellarate for the potential treatment of non-healing diabetic foot ulcers and is expected to enroll approximately 210 patients at up to ... once or twice for the potential treatment of non-healing diabetic foot ulcers. Other potential applications for TRC's Gene Activated Matrix(TM) ...

Advanced BioHealing and Regenesis Biomedical Form Co-Promotion Alliance for Dermagraft(R)

... by the Food and Drug Administration (FDA) for the treatment of diabetic foot ulcers (DFUs). DFUs, a complication of diabetes, affect more than 400,000 ... It currently markets the FDA-approved product Dermagraft, for diabetic foot ulcers. Additionally, the Company's development pipeline includes a ...

Organogenesis Debuts Educational Campaign for Sufferers of Chronic Leg and Foot Ulcers

... by doctors in treating hundreds of thousands of patients with diabetic foot ulcers (DFUs) and venous leg ulcers (VLUs) in the U.S. and around the ... and a more active approach is needed." Venous leg ulcers and diabetic foot ulcers are among the most frequently occurring chronic wounds, affecting ...

Exciton Technologies receives FDA approval to market exSALT(TM)

... SD7 Wound Dressing targets the advanced wound care market in preventing infection during the treatment of burn and chronic wounds such as diabetic foot ulcers and bed sores. By adjusting the dose of silver and expanding the number of product configurations, Exciton can target a greater portion of the ...

Cardium Announces New Orthobiologics Product Initiative Extending Gene Activated Matrix Technology to Deliver Bone Growth Factors

... and sustained cellular production of platelet-derived growth factor-B (PDGF-B) protein as a treatment for patients with non-healing diabetic foot ulcers. The Gene Activated Matrix technology allows for a broad spectrum of formulations which would include, but not be limited to, collagen, ...

Cardium Provides Update on Phase 2b Excellarate Clinical Study and Plans for Additional Tissue Repair Applications

... hard tissue injuries such as those affecting bone. Additional information regarding the use of Excellarate for the potential treatment of diabetic foot ulcers and other potential GAM product candidates is expected to be reported over the next several weeks and months. "We are pleased to ...

Kansas Delegation Defends NBAF, Refutes Washington Post

... over a twenty year period, NBAF would have a $3.5 billion impact on the Kansas economy. The proposed site would be a $451 million, 500,000 square foot building and will create as many as 500 high-paying, scientific federal jobs in the state of Kansas and will bring additional jobs in research ...

Alexandria Real Estate Equities, Inc. Signs Biopharmaceutical Company, Lilly, as Anchor New York City Tenant at the Alexandria Center for Science and Technology

... -- a science park in the heart of New York City. The Alexandria Center will ultimately consist of an approximately 1.1 million rentable square foot campus of first-class technical space uniquely designed with Alexandria's novel proprietary products to accommodate and foster collaboration among a ...